Virtu Financial’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Virtu Financial’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,809	Closed	-$3K	–	2215
2023 Q2	$3K	Buy	+11,809	New	+$2.72K	﹤0.01%	1425
2022 Q1	–	Sell	-12,200	Closed	-$28K	–	2304
2021 Q4	$28K	Buy	+12,200	New	+$34.7K	﹤0.01%	1469

Other funds holding ARDS

Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

Virtu Financial's ARDS Position: Q3 2023 in Review

Virtu Financial sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 11,809 shares — an estimated $3K sold.

Virtu Financial first reported a position in ARDS in Q4 2021 and held it in 2 quarters. The position peaked at $28K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

Virtu Financial reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 11,809 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $3K.
Virtu Financial first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Virtu Financial's Aridis Pharmaceuticals Inc. Common Stock position peaked at $28K in Q4 2021.
1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.